The Safety and Efficacy for In-segment Late Lumen Loss of the 'Genoss® SCB' Versus 'SeQuent® Please NEO' in Patients With Coronary ISR

NAEnrolling by invitationINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 19, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

January 31, 2027

Conditions

Coronary Arterial Disease (CAD)

Interventions

DEVICE

Sirolimus Coated PTCA Balloon Catheter(Genoss® SCB)

Drug Coated Balloon

DEVICE

Paclitaxel Coated PTCA Balloon Catheter(SeQuent® Please NEO)

Drug Coated Balloon

Trial Locations (1)

Seoul National University Bundang Hospital, Gyeonggi-do

All Listed Sponsors

collaborator

Synex Consulting Ltd

UNKNOWN

lead

Genoss Co., Ltd.

INDUSTRY